NCT00444145View on ClinicalTrials.gov

Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

December 31, 2009

Conditions
Larynx DiseaseGastroesophageal Reflux
Interventions
DRUG

Prevacid

30 mg bid for 3 months

PROCEDURE

Esophageal and Laryngeal Biopsies

repeat egd with biopsy after Prevacid 30 mg bid for 3 months

Trial Locations (1)

37232-5280

Vanderbilt University Medical Center, Endoscopy Lab, TVC 1410, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT00444145 - Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment? | Biotech Hunter | Biotech Hunter